Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search
  1. NCI-F Publications

Search
  1. Year Published:

Your search returned 8 results.
User Information
Export Records
  1. 1.   Dendrimer-induced leukocyte procoagulant activity depends on particle size and surface charge
  2. Dobrovolskaia, M. A.; Patri, A. K.; Potter, T. M.; Rodriguez, J. C.; Hall, J. B.; McNeil, S. E.
  3. Nanomedicine. 2012, Feb; 7(2): 245-256.
  1. 2.   DENDRONIZED BI-2-QUINOLINE LIGANDS AND THEIR METAL COMPLEXES: DENDRON SYNTHESIS AND METALLOASSEMBLY
  2. Patri, A.; Moorefield, C. N.; Newkome, G. R.
  3. Heterocycles. 2012, Jan; 84(2): 1023-1032.
  1. 3.   Newkome-Type Dendron-Stabilized Gold Nanoparticles: Synthesis, Reactivity, and Stability
  2. Cho, T. J.; Zangmeister, R. A.; MacCuspie, R. I.; Patri, A. K.; Hackley, V. A.
  3. Chemistry of Materials. 2011, May; 23(10): 2665-2676.
  1. 4.   Supramolecular complexes of quantum dots and a polyamidoamine (PAMAM)-folate derivative for molecular imaging of cancer cells
  2. Geraldo, D. A.; Duran-Lara, E. F.; Aguayo, D.; Cachau, R. E.; Tapia, J.; Esparza, R.; Yacaman, M. J.; Gonzalez-Nilo, F. D.; Santos, L. S.
  3. Analytical and Bioanalytical Chemistry. 2011, Apr; 400(2): 483-492.
  1. 5.   Nanoparticle therapeutics: a personal perspective
  2. McNeil, S. E.
  3. Wiley Interdisciplinary Reviews-Nanomedicine and Nanobiotechnology. 2009, May-Jun; 1(3): 264-271.
  1. 6.   Preclinical studies to understand nanoparticle interaction with the immune system and its potential effects on nanoparticle biodistribution
  2. Dobrovolskaia, M. A.; Aggarwal, P.; Hall, J. B.; McNeil, S. E.
  3. Molecular Pharmaceutics. 2008 5(4): 487-495.
  1. 7.   Analysis of fullerene-based nanomaterial in serum matrix by CE
  2. Chan, K. C.; Patri, A. K.; Veenstra, T. D.; McNeil, S. E.; Issaq, H. J.
  3. Electrophoresis. 2007, May; 28(10): 1518-1524.
  1. 8.   Dendrimers Effects on the Immune System: Insights into Toxicity and Therapeutic Utility
  2. Dobrovolskaia, Marina
  3. CURRENT PHARMACEUTICAL DESIGN. 2017 23(21): 3134-3141.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel